Array Biopharma Inc. (NASDAQ: ARRY), a biopharmaceutical company engaged in the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases, has seen a sharp rise in its shares in trading today.
Continue reading Biotech Stock of the Day; Array Biopharma Inc. (ARRY)